Anne B. Curtis, MD, SUNY Distinguished Professor and Charles and Mary Bauer Professor and chair of medicine, spoke about the benefits of heart monitor apps for cardiac patients in a presentation at the 2019 Consumer Electronics Show (CES) in Las Vegas.
Cytocybernetics, a UB spinoff founded by two Jacobs School of Medicine and Biomedical Sciences faculty members, has received a $250,000 Small Business Innovation Research award from the National Institute of Mental Health (NIMH) to move into a new market: neuronal drug development.
Michael E. Cain, MD, vice president for health sciences and dean of the Jacobs School of Medicine and Biomedical Sciences, has been awarded the UB President’s Medal, which is given in recognition of extraordinary service to the university.
John C. Biber III, a first-year student in the master’s program in anatomical sciences, has received a Mark Diamond Research Fund (MDRF) grant to support his thesis work in the laboratory of Yongho Bae, PhD, assistant professor of pathology and anatomical sciences.
Physicians in the Department of Emergency Medicine have implemented a new protocol for treating out-of-hospital cardiac arrest patients in Western New York that has more than doubled the patient survivor rate.
Anne B. Curtis, MD, SUNY Distinguished Professor and Charles and Mary Bauer Professor and chair of the Department of Medicine, is a member of the committee that has issued a new practice guideline for treating sudden cardiac death (SCD).
Researchers in the Department of Medicine have published a study that identifies a new way to predict which patients may be at a higher risk for heart failure after undergoing Transcatheter Aortic Valve Implantation (TAVR).
Umesh Sharma, MD, PhD, assistant professor of medicine, has received a five-year, $1 million grant from the National Institutes of Health (NIH) to study galectin-3, a protein involved in heart failure.
Anne B. Curtis, MD, SUNY Distinguished Professor and the Charles and Mary Bauer Professor and chair of the Department of Medicine, gave the opening plenary lecture at the International Academy of Cardiology’s 22nd World Congress on Heart Disease.
Surgeons and researchers sharing facilities in UB’s Clinical and Translational Science Institute and Kaleida Health’s Gates Vascular Institute (GVI) is resulting in collaboration, synergy and world-class innovation.
UB’s Buffalo Neuroimaging Analysis Center (BNAC) played a pivotal role in a phase III clinical trial of the first transcatheter cerebral embolic protection (TCEP) device to be approved by the Food and Drug Administration.